NEW YORK, April 12, 2013—Kantar Health, a leading global healthcare advisory firm, today announced that it will present at the Pharma China Forum 2013 in Shanghai on April 25, 2013.
Hettie Han, director at Kantar Health China, will present “Diabetic Patient Quality of Life and Outcomes in Urban China and Implications for Multinational Corporations.” The presentation will focus on:
- Diabetic patients’ quality of life
- Comparisons in outcomes across markets
- Disease burden as managed by current treatments
- Implications for multinational corporations in China
Pharma China Forum 2013 is a one-day seminar that provides insights into contemporary trends and issues of the Chinese pharmaceutical industry and marketplace today.
More information on the conference can be found at: http://www.pharmachinaonline.com/services/index_news.asp?id=250.
About Kantar Health
Kantar Health is a leading global healthcare advisory firm and trusted advisor to the world’s largest pharmaceutical, biotech, and medical device and diagnostic companies. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and marketing expertise to help clients launch products and differentiate their brands in the marketplace.
Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 700+ healthcare industry specialists work across the product lifecycle, from pre-clinical development to launch, acting as catalysts to successful decision making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. For more information, please visit www.kantarhealth.com.
+1 314 529 3062